2022年10月至2023年9月美国田纳西州中部成人rsv相关住院发生率

IF 4.2 4区医学 Q1 INFECTIOUS DISEASES

Influenza and Other Respiratory Viruses Pub Date : 2025-08-25 DOI:10.1111/irv.70150

Carlos G. Grijalva, Jesse O. Wrenn, Jonathan E. Schmitz, Karen F. Miller, Adrienne Baughman, Ian D. Jones, James D. Chappell, Natasha B. Halasa, Paul W. Blair, Yuwei Zhu, H. Keipp Talbot, Jonathan D. Casey, Fatimah S. Dawood, Diya Surie, Wesley H. Self, for the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network

{"title":"2022年10月至2023年9月美国田纳西州中部成人rsv相关住院发生率","authors":"Carlos G. Grijalva, Jesse O. Wrenn, Jonathan E. Schmitz, Karen F. Miller, Adrienne Baughman, Ian D. Jones, James D. Chappell, Natasha B. Halasa, Paul W. Blair, Yuwei Zhu, H. Keipp Talbot, Jonathan D. Casey, Fatimah S. Dawood, Diya Surie, Wesley H. Self, for the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network","doi":"10.1111/irv.70150","DOIUrl":null,"url":null,"abstract":"<p>We estimated the burden of RSV-associated hospitalizations in US adults 1 year prior to RSV vaccine introduction. The overall annual incidence rate of RSV-associated hospitalization was 31.47 (95% CI: 21.89–43.97) per 100,000 adults. Rates were 10-fold and 17-fold higher among adults 60 to 74 years and ≥ 75 years compared with adults 18 to 49 years old. This prospective assessment demonstrated the burden of RSV-associated hospitalizations among adults, with the highest hospitalization rates among adults ≥ 60 years old, in the year prior to RSV vaccine introduction.</p>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70150","citationCount":"0","resultStr":"{\"title\":\"Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023\",\"authors\":\"Carlos G. Grijalva, Jesse O. Wrenn, Jonathan E. Schmitz, Karen F. Miller, Adrienne Baughman, Ian D. Jones, James D. Chappell, Natasha B. Halasa, Paul W. Blair, Yuwei Zhu, H. Keipp Talbot, Jonathan D. Casey, Fatimah S. Dawood, Diya Surie, Wesley H. Self, for the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network\",\"doi\":\"10.1111/irv.70150\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We estimated the burden of RSV-associated hospitalizations in US adults 1 year prior to RSV vaccine introduction. The overall annual incidence rate of RSV-associated hospitalization was 31.47 (95% CI: 21.89–43.97) per 100,000 adults. Rates were 10-fold and 17-fold higher among adults 60 to 74 years and ≥ 75 years compared with adults 18 to 49 years old. This prospective assessment demonstrated the burden of RSV-associated hospitalizations among adults, with the highest hospitalization rates among adults ≥ 60 years old, in the year prior to RSV vaccine introduction.</p>\",\"PeriodicalId\":13544,\"journal\":{\"name\":\"Influenza and Other Respiratory Viruses\",\"volume\":\"19 8\",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70150\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Influenza and Other Respiratory Viruses\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/irv.70150\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.70150","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

我们在引入RSV疫苗前1年估计了美国成人RSV相关住院的负担。rsv相关住院的总年发病率为每10万成人31.47例（95% CI: 21.89-43.97）。与18 - 49岁的成年人相比，60 - 74岁和≥75岁的成年人的发病率分别高出10倍和17倍。这项前瞻性评估显示，在引入RSV疫苗前一年，成年人中与RSV相关的住院负担最高的是年龄≥60岁的成年人。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023

查看原文本刊更多论文

Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023

We estimated the burden of RSV-associated hospitalizations in US adults 1 year prior to RSV vaccine introduction. The overall annual incidence rate of RSV-associated hospitalization was 31.47 (95% CI: 21.89–43.97) per 100,000 adults. Rates were 10-fold and 17-fold higher among adults 60 to 74 years and ≥ 75 years compared with adults 18 to 49 years old. This prospective assessment demonstrated the burden of RSV-associated hospitalizations among adults, with the highest hospitalization rates among adults ≥ 60 years old, in the year prior to RSV vaccine introduction.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Influenza and Other Respiratory Viruses 医学-病毒学

CiteScore

7.20

自引率

4.50%

发文量

120

审稿时长

6-12 weeks

期刊介绍： Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.